{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:19:54Z","timestamp":1772803194454,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.metabol.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T02:31:57Z","timestamp":1392345117000},"page":"647-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels"],"prefix":"10.1016","volume":"63","author":[{"given":"Anna","family":"Wonnerth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina M.","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin A.","family":"Krychtiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter S.","family":"Speidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kaun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylie","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Wojta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingebjorg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2014.02.005_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.02.005_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jir.2005.25.241","article-title":"IL-6 transsignaling: the in vivo consequences","volume":"25","author":"Jones","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.metabol.2014.02.005_bb0015","first-page":"H1713","article-title":"Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner","volume":"260","author":"Ikeda","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-4804(03)00087-8","article-title":"Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization","volume":"111","author":"Wang","year":"2003","journal-title":"J Surg Res"},{"key":"10.1016\/j.metabol.2014.02.005_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2014.02.005_bb0030","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00004872-200310000-00002","article-title":"C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?","volume":"21","author":"Rattazzi","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2014.02.005_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0065-3233(04)68004-1","article-title":"Shared cytokine signaling receptors: structural insights from the gp130 system","volume":"68","author":"Boulanger","year":"2004","journal-title":"Adv Protein Chem"},{"issue":"Pt 2","key":"10.1016\/j.metabol.2014.02.005_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3000281","article-title":"Soluble receptors for cytokines and growth factors: generation and biological function","volume":"300","author":"Rose-John","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2014.02.005_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1105674","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0050","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.metabol.2014.02.005_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-2478(00)00157-7","article-title":"Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production","volume":"71","author":"Igaz","year":"2000","journal-title":"Immunol Lett"},{"key":"10.1016\/j.metabol.2014.02.005_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2014.02.005_bb0065","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.4049\/jimmunol.163.8.4583","article-title":"Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor","volume":"163","author":"Klouche","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0070","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1073\/pnas.0501794102","article-title":"IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation","volume":"102","author":"McLoughlin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2014.02.005_bb0075","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V82.4.1120.1120","article-title":"Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130","volume":"82","author":"Narazaki","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2014.02.005_bb0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","article-title":"Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses","volume":"268","author":"Jostock","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.metabol.2014.02.005_bb0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2014.02.005_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09629359890875","article-title":"Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis","volume":"7","author":"Robak","year":"1998","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.metabol.2014.02.005_bb0095","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2174\/138161209788489140","article-title":"Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease","volume":"15","author":"Rose-John","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2014.02.005_bb0100","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.171.6.3202","article-title":"Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130","volume":"171","author":"Nowell","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.0801217","article-title":"Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6\/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model","volume":"184","author":"Matsumoto","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.regpep.2007.09.031","article-title":"A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)\/gp130 is associated with myocardial infarction in a hypertensive population","volume":"146","author":"Benrick","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.metabol.2014.02.005_bb0115","first-page":"325","article-title":"Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia","volume":"13","author":"Hjerkinn","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.metabol.2014.02.005_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cytogfr.2006.09.003","article-title":"Interleukin-6 trans-signaling in inflammatory bowel disease","volume":"17","author":"Mitsuyama","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.metabol.2014.02.005_bb0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.atherosclerosis.2010.08.074","article-title":"Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance","volume":"213","author":"Zuliani","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2014.02.005_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00380-004-0770-z","article-title":"Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure","volume":"19","author":"Hirota","year":"2004","journal-title":"Heart Vessels"},{"key":"10.1016\/j.metabol.2014.02.005_bb0140","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.metabol.2013.01.019","article-title":"Components of the Interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness","volume":"62","author":"Weiss","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.02.005_bb0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/HJH.0b013e32831e9948","article-title":"Correlation of soluble gp130 serum concentrations with arterial blood pressure","volume":"27","author":"Inta","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2014.02.005_bb0150","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db09-1316","article-title":"Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome","volume":"59","author":"Nikolajuk","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.02.005_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00421-010-1362-5","article-title":"Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients","volume":"109","author":"Hansen","year":"2010","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0160","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.02.005_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0102-75","article-title":"Interleukin-6-deficient mice develop mature-onset obesity","volume":"8","author":"Wallenius","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2014.02.005_bb0170","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2007-07-102137","article-title":"Transgenic blockade of interleukin 6 transsignaling abrogates inflammation","volume":"111","author":"Rabe","year":"2008","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2014.02.005_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200262002-00001","article-title":"The epidemiology of smoking: health consequences and benefits of cessation","volume":"62","author":"Fagerstrom","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2014.02.005_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2013.09.013","article-title":"Cigarette smoke induces molecular responses in respiratory tissues of ApoE mice that are progressively deactivated upon cessation","volume":"314","author":"Boue","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.metabol.2014.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201110-1792OC","article-title":"Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease","volume":"185","author":"Celli","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.metabol.2014.02.005_bb0190","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/CS20130110","article-title":"Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C)","volume":"125","author":"Hubeau","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2014.02.005_bb0195","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2007-01-067918","article-title":"Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils","volume":"110","author":"Chalaris","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2014.02.005_bb0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0167-4889(02)00325-7","article-title":"The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases","volume":"1592","author":"Kallen","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2014.02.005_bb0205","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.4049\/jimmunol.152.10.4958","article-title":"The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site","volume":"152","author":"Mullberg","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2014.02.005_bb0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.gene.6364120","article-title":"Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced","volume":"5","author":"Galicia","year":"2004","journal-title":"Genes Immun"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:04:02Z","timestamp":1758427442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0026049514000444"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.02.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}